In this AIDS Commentary, Drs. Spooner, Lane, and Masur of the National Institutes of Health present the results of clinical trials, meta-analyses, and observational studies of antiretroviral therapy administered to patients infected with human immunodeficiency virus type 1. This compilation updates a similar review published as an AIDS Commentary in Clinical Infectious Diseases (1995;20:1145-51). As the number of effective agents available to physicians grows and as combination therapies are evaluated, the most effective strategies to be used in treating patients are more difficult to define. These tables are based upon published articles and abstracts and, as in the first review, both the results of each study and the reviewers' interpretation are presented. The studies
1995 [40] 1996 [41] 73 <500 (RNA, >20,000 copies/mL) • Dosages of drugs in combinations are the same as those for monotherapy, except as noted. 
